Eric Yuen M.D.

Eric Yuen M.D.

Board Member at Asceneuron

Are you Eric Yuen M.D.? Claim your profile
 
  • IDENTIFY executive and board member connections in Eric Yuen M.D.'s network.
  • FOLLOW changes in Eric Yuen M.D.'s employment.
  • CONNECT with Eric Yuen M.D. through your network of contacts.

Eric Yuen M.D.'s Executive Work History


Current
Advisor,
Advisor
Equilar on 05/17/2022
RiboNova
Board Member,
Board Member
Equilar on 09/06/2022
Asceneuron
Advisor,
Advisor
Equilar on 06/20/2022
NITROME BIOSCIENCES, INC
Past
To view Eric Yuen M.D.'s complete executive work history,
 

Eric Yuen M.D.'s Biography


Dr Eric Yuen, has over 25 years of clinical development experience in central nervous system (CNS) pathologies and has led multiple Phase I-IV development programs for biologics and small molecules obtaining numerous regulatory approvals. He is currently Chief Medical Officer at Talee Bio Inc which he co-founded in addition to RiboNova Inc. He has held senior positions in several biotech companies including as Chief Medical Officer at Inozyme Pharma and Ultragenyx Pharmaceuticals. Dr Yuen received his M.D. from the Pritzker School of Medicine at the University of Chicago and completed his neurology training at the University of California at San Francisco. He holds a B.S. in Physics and Biology with Academic Distinction from Stanford University.

Source: Asceneuron on 09/06/2022

 

By accessing ExecAtlas, you can view bios, network, connections and references of industry leading executives like Eric Yuen M.D.. More specifically, you'll be able to:

  • IDENTIFY executive and board member connections in Eric Yuen M.D.'s network.
  • FOLLOW changes in Eric Yuen M.D.'s employment.
  • CONNECT with Eric Yuen M.D. through your network of contacts.
 

Access over 1,500,000 executive and board member profiles.

Example: Eric Yuen M.D.

Eric Yuen M.D.'s Connections (104)


Colin Kahrs Ph.D.
Head of Intellectual Property, Asceneuron
Lior Teitelbaum MSc, MBA
Principal, Venture Investments, Johnson & Johnson Innovation, LLC
Bruno Permanne Ph.D.
Senior Director & Head of Preclinical Development, Asceneuron
Dr. Joseph Schlessinger
Advisor, Celldex Therapeutics, Inc.
Keith S. Manchester M.D.
Board Member, Roivant Sciences Ltd.
Gaston Picchio Ph.D.
Former Chief Development Officer, Arbutus Biopharma Corporation
Xinan Chen M.D.
Executive Vice President, Huya Bioscience International, LLC
Todd Erik Zavodnick
Chief Executive Officer, Dermavant, Roivant Sciences Ltd.
Terrie J. Curran
President, Chief Executive Officer and Director, Phathom Pharmaceuticals, Inc.
Catherine Moukheibir
Board Member, Ironwood Pharmaceuticals, Inc.